What the Research Says
L-Carnitine is a nutrient involved in energy metabolism and has been extensively studied for its potential health benefits across various conditions. In cardiovascular medicine, DiNicolantonio et al. (2013) conducted a systematic review and meta-analysis that found L-carnitine supplementation significantly reduced mortality post-myocardial infarction (MI), with a 27% reduction in risk. This underscores its strong evidence for supporting cardiovascular health.
In the context of metabolic disorders, Mirrafiei et al. (2024) performed a systematic review and meta-analysis of 21 randomized controlled trials involving 2041 participants with type 2 diabetes. The study demonstrated that L-carnitine supplementation significantly improved cardiometabolic markers, including reductions in BMI, HbA1c, LDL cholesterol, triglycerides, total cholesterol, and fasting plasma glucose. Similarly, Li et al. (2023) reviewed 15 trials with 12,221 adults and reported that L-carnitine supplementation improved glucolipid metabolism by reducing fasting blood glucose, insulin resistance, triglycerides, total cholesterol, LDL cholesterol, and ALT levels.
Despite these benefits, caution is warranted due to findings from Koeth et al. (2013), who linked high doses of carnitine to gut-bacteria-mediated production of trimethylamine N-oxide (TMAO), a compound associated with an increased risk of atherosclerosis. This finding has sparked debate regarding the long-term safety of chronic high-dose L-carnitine supplementation.
In sports nutrition, while L-carnitine L-tartrate shows promise for recovery, claims about fat-burning in healthy adults are overstated (Spiering et al., 2007). Additionally, studies on other conditions such as septic shock and polycystic ovary syndrome (PCOS) have yielded mixed results. For instance, Guedes et al. (2022) found no significant effect of L-carnitine supplementation on 28-day mortality in septic shock patients, while Mohd Shukri et al. (2022) reported moderate evidence that L-carnitine improved lipid profiles and fasting glucose levels in women with PCOS.
Overall, L-Carnitine demonstrates strong evidence for cardiovascular benefits and metabolic support, particularly in individuals with type 2 diabetes, but its use should be tailored to individual needs and considerations of
